https://www.selleckchem.com/pr....oducts/Sorafenib-Tos
5% of group A, but in only 27.4% of group B. Primary CLA resistance was higher in Southern and Eastern Europe (ORadj = 3.44, 95%CI 2.22-5.32, p less then 0.001 and 2.62, 95% CI 1.63-4.22 p less then 0.001, respectively) compared to Northern/Western Europe. Children born outside Europe showed higher primary MET resistance (ORadj = 3.81, 95%CI 2.25-6.45, p less then 0.001). Treatment success in group A reached only 79.8% (568/712) with 7-14 days triple therapy tailored to antibiotic susceptibility. Conclusion Peptic ulcers are
إعجاب
علق
شارك
